India’s 100 Richest
THE TIMES OF INDIA GROUP76 | FORBES ASIA OCTOBER 2018
Magnate’s fortune jumped after he sold a 10% stake in his Mankind Pharma to Indian private equity firm ChrysCapital for $320 million. The
deal boosted Mankind’s valuation to $3.2 billion. ChrysCapital was an early investor in the firm but cashed out in 2015 only to reenter again as
Mankind prepares for an IPO. A champion of low-cost generics, Juneja, who shares his wealth with his family, uses Bollywood stars to market
his products.
RAMESH JUNEJA: BOOSTER SHOT